# FDA 483 - Louisville Reproductive Center - April 28, 2025

Source: https://www.keypedia.com/records/483/louisville-reproductive-center/29567dc0-8b65-4a0a-afd3-79a86c012fe4

> FDA 483 for Louisville Reproductive Center on April 28, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Louisville Reproductive Center
- Inspection Date: 2025-04-28
- Product Type: biologics
- Office Name: FDA District Office — Cincinnati, Ohio
- Summary: The FDA inspected Louisville Reproductive Center, a human tissue establishment, from April 23-28, 2025. The inspection revealed significant deficiencies in donor eligibility determination, specifically regarding the testing of semen donors for relevant communicable disease agents and the quarantine of HCT/Ps. These issues indicate a failure to ensure the safety and eligibility of donor tissues.

## Related Documents

- [WARNING_LETTER - 2017-06-15](https://www.keypedia.com/records/warning_letter/louisville-reproductive-center/a9f1c684-be68-4d8c-8121-0eff4d117497)
- [483 - 2021-04-08](https://www.keypedia.com/records/483/louisville-reproductive-center/872e14d0-2745-42ba-a15d-d08db1d00f46)
- [483 - 2025-04-28](https://www.keypedia.com/records/483/louisville-reproductive-center/e470cebd-8996-4a43-9324-227bd02f7bf4)
- [WARNING_LETTER - 2025-04-28](https://www.keypedia.com/records/warning_letter/louisville-reproductive-center/442e539a-ef07-48cb-bca7-06d86875f243)

## Related Officers

- [Jennifer L. Sheehan](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/louisville-reproductive-center/b1b4afdf-389d-463a-9b58-d06525fee135

Office: https://www.keypedia.com/offices/fda-district-office-cincinnati-ohio/b4972fd9-9db9-4cc6-9a4c-0146959c9d74